J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.74 CNY 1.18% Market Closed
Market Cap: 25.6B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Jafron Biomedical Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jafron Biomedical Co Ltd
Accounts Receivables Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
J
Jafron Biomedical Co Ltd
SZSE:300529
Accounts Receivables
ÂĄ72m
CAGR 3-Years
-36%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accounts Receivables
ÂĄ41.4m
CAGR 3-Years
-2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accounts Receivables
ÂĄ1.1B
CAGR 3-Years
10%
CAGR 5-Years
-5%
CAGR 10-Years
7%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accounts Receivables
ÂĄ4B
CAGR 3-Years
28%
CAGR 5-Years
17%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Accounts Receivables
ÂĄ2.1B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
10%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accounts Receivables
ÂĄ3.3B
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jafron Biomedical Co Ltd's Accounts Receivables?
Accounts Receivables
72m CNY

Based on the financial report for Jun 30, 2024, Jafron Biomedical Co Ltd's Accounts Receivables amounts to 72m CNY.

What is Jafron Biomedical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-16%

Over the last year, the Accounts Receivables growth was -49%. The average annual Accounts Receivables growth rates for Jafron Biomedical Co Ltd have been -36% over the past three years , -16% over the past five years .

Back to Top